摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(2,6-dichlorophenyl)-3-(methylethyl)-6-({4-[2-(phosphonooxy)ethoxy]phenyl}methyl)-5-hydropyrazolo[5,4-d]pyrimidin-4-one | 784210-90-8

中文名称
——
中文别名
——
英文名称
1-(2,6-dichlorophenyl)-3-(methylethyl)-6-({4-[2-(phosphonooxy)ethoxy]phenyl}methyl)-5-hydropyrazolo[5,4-d]pyrimidin-4-one
英文别名
2-[4-[[1-(2,6-dichlorophenyl)-4-oxo-3-propan-2-yl-5H-pyrazolo[3,4-d]pyrimidin-6-yl]methyl]phenoxy]ethyl dihydrogen phosphate
1-(2,6-dichlorophenyl)-3-(methylethyl)-6-({4-[2-(phosphonooxy)ethoxy]phenyl}methyl)-5-hydropyrazolo[5,4-d]pyrimidin-4-one化学式
CAS
784210-90-8
化学式
C23H23Cl2N4O6P
mdl
——
分子量
553.339
InChiKey
WRTJZIYAMYZALI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    135
  • 氢给体数:
    3
  • 氢受体数:
    8

反应信息

点击查看最新优质反应信息

文献信息

  • Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
    申请人:GPC Biotech, Inc.
    公开号:US20040266854A1
    公开(公告)日:2004-12-30
    The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, ultimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.
    这项发明涉及新型细胞周期依赖性激酶抑制剂(cdks),具体而言,但不仅限于作为cdk/cyclin复合物的抑制剂。如本文所述,本发明的抑制剂能够抑制细胞周期机制,因此可能有助于调节细胞周期进程,最终控制细胞生长和分化。这样的化合物对于治疗患有与过度细胞增殖相关的疾病的患者将会很有用。
  • INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO
    申请人:Bockovich Nicholas
    公开号:US20090209530A1
    公开(公告)日:2009-08-20
    The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, ultimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.
  • US7605175B2
    申请人:——
    公开号:US7605175B2
    公开(公告)日:2009-10-20
  • US7786112B2
    申请人:——
    公开号:US7786112B2
    公开(公告)日:2010-08-31
  • US7893057B2
    申请人:——
    公开号:US7893057B2
    公开(公告)日:2011-02-22
查看更多